Since Smad2 undergoes LOH in some cancers [44], it is considered as a tumor suppressor, which was supported by the observation that its expression at mRNA level was lower in invasive breast cancers compared to normal breast tissues [45]. This evidence concerns the gene SMAD2 and breast carcinoma.